GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (LTS:0A9B) » Definitions » Net Income From Continuing Operations

Synlab AG (LTS:0A9B) Net Income From Continuing Operations : €68 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Synlab AG's net income from continuing operations for the three months ended in Mar. 2024 was €54 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was €68 Mil.

Synlab AG Net Income From Continuing Operations Historical Data

The historical data trend for Synlab AG's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Net Income From Continuing Operations Chart

Synlab AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
315.49 914.53 231.68 59.16

Synlab AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.27 37.84 13.87 -37.82 53.92

Synlab AG Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synlab AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (LTS:0A9B) » Definitions » Net Income From Continuing Operations
Comparable Companies
XTER:NN6 TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT EXAS XPAR:BIM RVTY XPAR:ERF ASX:SHL QGEN
Traded in Other Exchanges
N/A
Address
Moosacher Strasse 88, Munich, BY, DEU, 80809
Website
https://www.synlab.com
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG Headlines

No Headlines